Skip to content

Sana Biotechnology SANA Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$47.21M+19.7%-$58.83M-39.6%-$42.15M+55.1%-$93.8M-89.9%-$49.39M-0.7%
$2.39M$3.2M+10.3%$2.9M-20.5%$3.65M
$5.66M-10.7%$6.34M+15.7%$5.48M-17.4%$6.63M-5.6%$7.02M+9.1%
-$37.38M-14.5%-$32.64M-10.9%-$29.43M+11.1%-$33.1M+32.0%-$48.66M-3.2%
$288K-67.0%$873K+2,029%$41K$136K-68.8%
$49.44M+400%-$16.5M+65.7%-$48.03M-725%$7.68M-53.7%$16.6M-64.7%
-$128K-101%$17.65M-83.9%$109.54M+19,426%$561K-42.9%$982K+52.7%
$11.93M+138%-$31.49M-$24.86M+20.0%-$31.07M
-$37.67M-12.4%-$33.51M-13.7%-$29.47M+10.7%-$32.99M+32.4%-$48.79M-2.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Sana Biotechnology generate?
Sana Biotechnology (SANA) generated -$132.6M in operating cash flow over the trailing twelve months.
What is Sana Biotechnology's free cash flow?
After $1.3M of capital expenditures, Sana Biotechnology's free cash flow was -$133.6M over the trailing twelve months, up 40.3% year over year.
Where does Sana Biotechnology's cash flow data come from?
Every line is extracted from Sana Biotechnology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.